L3Harris Technologies, Inc.
LHX
$0.00
+0.59%
L3Harris Technologies is a major aerospace and defense contractor specializing in advanced communication systems, sensors, avionics, and space-based systems. It is a key player in the defense industrial base, with a diversified portfolio built through strategic acquisitions in areas like unmanned systems and solid rocket motors.…
LHX
L3Harris Technologies, Inc.
$0.00
Related headlines
LHX 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on L3Harris Technologies, Inc.'s 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
7 analysts
Implied Upside
—
vs. current price
Analyst Count
7
covering this stock
Price Range
$0 - $0
Analyst target range
Based on the provided institutional ratings, Wall Street sentiment is generally positive. Recent actions include Citigroup and JP Morgan maintaining 'Buy'/'Overweight' ratings, Morgan Stanley upgrading to 'Overweight', and RBC Capital and UBS maintaining 'Sector Perform'/'Neutral' stances. The consensus appears to lean towards a favorable outlook, with several firms endorsing the stock. However, specific consensus target price and detailed ratings distribution data are not available in the provided inputs.
LHX Technical Analysis
The stock has demonstrated strong long-term performance, rising 64.9% over the past year and significantly outperforming the broader market, as evidenced by a relative strength of 48.97. The price has climbed from around $296 in early October 2025 to a recent close of $345.15, though it has retreated from its 52-week high of $379.23.
In the short term, the stock has shown volatility. Over the past three months, it gained 17.57%, strongly outperforming the S&P 500's decline of 4.63%. However, in the most recent month, it declined 5.32%, slightly underperforming the market's 5.25% drop, indicating a recent pullback.
The current price of $345.15 sits approximately 9.0% below the 52-week high of $379.23 and is 76.3% above the 52-week low of $195.72, positioning it in the upper half of its annual range. The stock recently experienced a maximum drawdown of -11.23% from its peak during the provided period.
Beta
0.75
0.75x market volatility
Max Drawdown
-11.2%
Largest decline past year
52-Week Range
$196-$379
Price range past year
Annual Return
+68.0%
Cumulative gain past year
| Period | LHX Return | S&P 500 |
|---|---|---|
| 1m | -3.3% | -4.3% |
| 3m | +16.9% | -4.0% |
| 6m | +19.7% | -2.0% |
| 1y | +68.0% | +22.2% |
| ytd | +16.9% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LHX Fundamental Analysis
Revenue growth has been modest but positive, with the latest quarterly revenue of $5.65 billion representing a 2.26% year-over-year increase. Profitability metrics, however, show pressure; the net margin for Q4 2025 was 5.3%, down from 8.2% in the prior-year quarter, and the quarterly EPS of $1.60 declined from $2.38 in the year-ago period, indicating margin compression.
The company maintains a moderate debt-to-equity ratio of 0.53, suggesting a reasonable capital structure. Cash flow generation is solid, with trailing twelve-month free cash flow reported at $2.68 billion, providing financial flexibility for dividends, share repurchases, and debt management.
Operational efficiency metrics are mixed. Return on Equity (ROE) stands at 8.18%, which is modest. The current ratio of 1.19 indicates adequate short-term liquidity. The company's beta of 0.61 suggests its stock is less volatile than the overall market.
Quarterly Revenue
$5.6B
2026-01
Revenue YoY Growth
+0.02%
YoY Comparison
Gross Margin
+0.25%
Latest Quarter
Free Cash Flow
$2.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LHX Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E is 35.53, while the forward P/E is 25.35, indicating expectations for future earnings growth. The Price-to-Sales (P/S) ratio is 2.61, and the Enterprise Value-to-Sales (EV/Sales) is 3.44.
Peer comparison data is not available in the provided inputs. The valuation appears to be pricing in growth, supported by a forward P/E that is lower than the trailing multiple. The PEG ratio of 4.26, based on trailing earnings, suggests the stock may be trading at a premium relative to its historical growth rate.
PE
35.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -33x~63x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.7x
Enterprise Value Multiple

